• Product NameSarcosine
  • CasNo. 107-97-1
  • MFC3H7NO2
  • MW89.0941
  • Purity
  • Appearancewhite crystalline powder
  • Packing
  • Contact usInquiry

Product Details

CasNo: 107-97-1

MF: C3H7NO2

Appearance: white crystalline powder

Chinese Factory Supply Sarcosine,Wholesale 107-97-1 Reasonable Price

  • Molecular Formula:C3H7NO2
  • Molecular Weight:89.0941
  • Appearance/Colour:white crystalline powder 
  • Vapor Pressure:0.184mmHg at 25°C 
  • Melting Point:208-212 °C (dec.)(lit.) 
  • Refractive Index:1.431 
  • Boiling Point:195.1 °C at 760 mmHg 
  • PKA:2.21(at 25℃) 
  • Flash Point:71.8 °C 
  • PSA:49.33000 
  • Density:1.093 g/cm3  
  • LogP:-0.31870 

Sarcosine(Cas 107-97-1) Usage

Description

Sarcosine, also known as N-methylglycine or monomethylglycine, is an amino acid derivative and an intermediate in the metabolic pathway of glycine. Structurally, it is an N-alkylglycine, specifically the N-methyl derivative of glycine. It exists as a zwitterion in neutral pH, represented as CH₃N⁺(H)₂CH₂CO₂⁻, and is typically obtained as a white, water-soluble powder.

Uses

Sarcosine has shown potential as a cognitive enhancer, particularly in the treatment of certain mental health conditions such as schizophrenia. By increasing glycine concentrations in the brain, sarcosine may enhance NMDA receptor activation, which is believed to contribute to its cognitive-enhancing effects. Sarcosine has been studied for its therapeutic effects in schizophrenia treatment. Research suggests that supplementation with sarcosine, in addition to standard antipsychotic drug therapy, can lead to significant reductions in both positive and negative symptoms of schizophrenia, as well as improvements in general psychopathological and neurocognitive symptoms.

InChI:InChI=1/C3H7NO2/c1-4-2-3(5)6/h4H,2H2,1H3,(H,5,6)

107-97-1 Relevant articles

Ketamine, benzoate, and sarcosine for treating depression

Yu-Jung Cheng a b, Chieh-Hsin Lin c d e f, Hsien-Yuan Lane c d g h

, Neuropharmacology Volume 223, 1 February 2023, 109351

Studies have demonstrated the beneficial therapeutic effects of sarcosine, benzoate, and ketamine (including esketamine and arketamine) on depression. These drugs mainly act by modulating N-methyl-d-aspartate glutamate receptors (NMDARs) and reducing inflammation in the brain.

Perthamides C and D, two new potent anti-inflammatory cyclopeptides from a Solomon Lithistid sponge Theonella swinhoei

Festa, Carmen,De Marino, Simona,Sepe, Valentina,Monti, Maria Chiara,Luciano, Paolo,D'Auria, Maria Valeria,Débitus, Cecile,Bucci, Mariarosaria,Vellecco, Valentina,Zampella, Angela

, p. 10424 - 10429 (2009)

Two new metabolites, perthamides C and D...

Chemically reactive supramolecular hydrogel coupled with a signal amplification system for enhanced analyte sensitivity

Yoshii, Tatsuyuki,Onogi, Shoji,Shigemitsu, Hajime,Hamachi, Itaru

, p. 3360 - 3365 (2015)

Multicomponent supramolecular hydrogels ...

Acceptorless dehydrogenation of primary alcohols to carboxylic acids by self-supported NHC-Ru single-site catalysts

Yin, Shenxiang,Zheng, Qingshu,Chen, Jie,Tu, Tao

, p. 165 - 172 (2022/03/23)

The acceptorless dehydrogenation of dive...

A Cleavable C2-Symmetric trans-Cyclooctene Enables Fast and Complete Bioorthogonal Disassembly of Molecular Probes

Carlson, Jonathan C. T.,Haider, Maximilian,Herrmann, Barbara,Klubnick, Jenna,Mikula, Hannes,Sohr, Barbara,Weissleder, Ralph,Wilkovitsch, Martin

supporting information, p. 19132 - 19141 (2020/11/13)

Bioorthogonal chemistry is bridging the ...

Relevant Products